Elevation of Ceramide in Senescence: Role of Sphingolipid Metabolism
- 5 November 2013
- book chapter
- Published by Springer Nature
- p. 81-88
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Sphingolipid Modulation: A Strategy for Cancer TherapyAnti-Cancer Agents in Medicinal Chemistry, 2012
- Chain length-specific properties of ceramidesProgress in Lipid Research, 2012
- Ceramide-Based Therapeutics for the Treatment of CancerAnti-Cancer Agents in Medicinal Chemistry, 2011
- Sphingolipid Metabolism and Leukemia: A Potential for Novel Therapeutic ApproachesAnti-Cancer Agents in Medicinal Chemistry, 2011
- Sphingolipids in cancerCancer and Metastasis Reviews, 2011
- Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidasesBritish Journal of Pharmacology, 2011
- Metabolism of short-chain ceramide by human cancer cells—Implications for therapeutic approachesBiochemical Pharmacology, 2010
- Study of Apoptosis Induction and Deoxycytidine Kinase/Cytidine Deaminase Modulation in the Synergistic Interaction of a Novel Ceramide Analog and Gemcitabine in Pancreatic Cancer CellsNucleosides, Nucleotides & Nucleic Acids, 2010
- NGcGM3 Ganglioside: A Privileged Target for Cancer VaccinesJournal of Immunology Research, 2010
- Telomere DiseasesNew England Journal of Medicine, 2009